![Marie-Louise Fjaellskog](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marie-Louise Fjaellskog
Directeur Technique/Scientifique/R&D chez
EXSCIENTIA PLC
Fortune : - $ au 31/05/2026
Profil
Marie-Louise Fjaellskog currently works at Faron Pharmaceuticals Oy, as Non-Executive Director from 2023, Biovica International AB, as Director from 2020, Lytix Biopharma AS, as Independent Non-Executive Director from 2021, the University of Uppsala, as Associate Professor from 2008, and Exscientia Ltd., as Chief Medical Officer & Clinical Development Lead from 2024.
Dr. Fjaellskog also formerly worked at Infinity Pharmaceuticals, Inc., as Vice President-Clinical Development from 2018 to 2019, Merus NV, as Vice President-Clinical Development from 2019 to 2020, and Sensei Biotherapeutics, Inc., as Chief Medical Officer from 2020 to 2021.
Dr. Fjaellskog received her doctorate degree from the University of Uppsala.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Marie-Louise Fjaellskog
| Sociétés | Poste | Début |
|---|---|---|
| FARON PHARMACEUTICALS OY | Directeur/Membre du Conseil | 22/09/2023 |
| BIOVICA INTERNATIONAL AB | Directeur/Membre du Conseil | 01/01/2020 |
| LYTIX BIOPHARMA ASA | Directeur/Membre du Conseil | 01/01/2021 |
| EXSCIENTIA PLC | Directeur Technique/Scientifique/R&D | 06/06/2024 |
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/12/2008 |
Anciens postes connus de Marie-Louise Fjaellskog
| Sociétés | Poste | Fin |
|---|---|---|
| SENSEI BIOTHERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2021 |
| MERUS N.V. | Directeur Technique/Scientifique/R&D | 01/06/2020 |
| INFINITY PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/04/2019 |
Formation de Marie-Louise Fjaellskog
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
59
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Infinity Pharmaceuticals, Inc.
 Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Faron Pharmaceuticals Oy
 Faron Pharmaceuticals Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Merus NV
 Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
Lytix Biopharma AS
 Lytix Biopharma AS Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company that develops novel cancer immunotherapies | Health Technology |
Biovica International AB
 Biovica International AB BiotechnologyHealth Technology Operates as a biotechnology company which develops and commercializes blood-based biomarker assays | Health Technology |
Sensei Biotherapeutics, Inc.
 Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
Exscientia Plc
 Exscientia Plc Packaged SoftwareTechnology Services Function as an investment holding company whose subsidiaries provides artificial intelligence and machine learning services | Technology Services |
